2026-09-14 · Meeker David P (President and CEO) · SELL
2026-09-14 · Meeker David P (President and CEO) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders320
Shares held91,166,981
Value$9.27B
Percent of shares outstanding132.41%
As of quarter end2026-06-30
RECENT NEWS
RYTM: Kuehn Law Encourages Investors of Rhythm Pharmaceuticals, Inc. to Contact Law Firm
Rhythm Pharmaceuticals Announces Health Canada Approval of IMCIVREE® (setmelanotide) for Weight Management in Adult and Pediatric Patients 4 years of Age and Older with Acquired Hypothalamic Obesity
Rhythm Pharmaceuticals presents at Morgan Stanley healthcare conference
Rhythm Pharmaceuticals president and CEO Meeker sells $5.13m in stock
Rhythm Pharmaceuticals presents setmelanotide data in pediatric hypothalamic obesity